BE1002058A4 - Compositions pharmaceutiques a base d'urokinase. - Google Patents

Compositions pharmaceutiques a base d'urokinase. Download PDF

Info

Publication number
BE1002058A4
BE1002058A4 BE8701102A BE8701102A BE1002058A4 BE 1002058 A4 BE1002058 A4 BE 1002058A4 BE 8701102 A BE8701102 A BE 8701102A BE 8701102 A BE8701102 A BE 8701102A BE 1002058 A4 BE1002058 A4 BE 1002058A4
Authority
BE
Belgium
Prior art keywords
urokinase
pharmaceutical compositions
compositions based
thromolitic
pro
Prior art date
Application number
BE8701102A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868623823A external-priority patent/GB8623823D0/en
Priority claimed from GB868628741A external-priority patent/GB8628741D0/en
Priority claimed from GB878707551A external-priority patent/GB8707551D0/en
Priority claimed from GB878715678A external-priority patent/GB8715678D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1002058A4 publication Critical patent/BE1002058A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE8701102A 1986-10-03 1987-09-28 Compositions pharmaceutiques a base d'urokinase. BE1002058A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868623823A GB8623823D0 (en) 1986-10-03 1986-10-03 Therapeutic lysis of fibrin blood clots
GB868628741A GB8628741D0 (en) 1986-12-02 1986-12-02 Therapeutic lysis of fibrin blood clots
GB878707551A GB8707551D0 (en) 1987-03-30 1987-03-30 Therapeutic lysis of fibrin blood clots
GB878715678A GB8715678D0 (en) 1987-07-03 1987-07-03 Therapeutic lysis of fibrin blood clots

Publications (1)

Publication Number Publication Date
BE1002058A4 true BE1002058A4 (fr) 1990-06-12

Family

ID=27449820

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8701102A BE1002058A4 (fr) 1986-10-03 1987-09-28 Compositions pharmaceutiques a base d'urokinase.

Country Status (19)

Country Link
KR (1) KR960002738B1 (sv)
AU (1) AU7932587A (sv)
BE (1) BE1002058A4 (sv)
CA (1) CA1323300C (sv)
CH (1) CH678599A5 (sv)
DE (1) DE3731776A1 (sv)
DK (1) DK519287A (sv)
FI (1) FI874320A (sv)
FR (1) FR2605225B1 (sv)
GR (1) GR871528B (sv)
HU (1) HUT47032A (sv)
IL (1) IL84061A0 (sv)
IT (1) IT1230114B (sv)
LU (1) LU87007A1 (sv)
MY (1) MY101943A (sv)
NL (1) NL8702234A (sv)
NO (1) NO874143L (sv)
PT (1) PT85848B (sv)
SE (1) SE466531B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS/RRM: 34048840; V. GUREWICH: "Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator", & J. AM. COLL. CARDIOL. 1987, vol. 10, no. 5, suppl. B, p16B-21B *
DIALOG 06028943, MEDLINE 83-89/JUL; D. COLLEN et al.: "Synergism of thrombolytic agents in vivo", & CIRCULATION, Oct. 1986, 74(4), p838-42 *
DIALOG 06069339, MEDLINE 83-89/JUL; D. COLLEN et al.: "Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro", & THROMB. HAEMOST., Aug. 20 1986, 56(1), p35-9 *

Also Published As

Publication number Publication date
KR880004821A (ko) 1988-06-27
IL84061A0 (en) 1988-03-31
CA1323300C (en) 1993-10-19
SE466531B (sv) 1992-03-02
FR2605225A1 (fr) 1988-04-22
DK519287D0 (da) 1987-10-02
NO874143D0 (no) 1987-10-01
IT1230114B (it) 1991-10-07
GR871528B (en) 1988-02-23
FI874320A (fi) 1988-04-04
AU7932587A (en) 1988-04-14
PT85848B (en) 1990-01-12
LU87007A1 (fr) 1988-05-03
PT85848A (en) 1987-11-01
DE3731776A1 (de) 1988-05-05
DK519287A (da) 1988-04-04
MY101943A (en) 1992-02-15
FR2605225B1 (fr) 1994-02-04
IT8748444A0 (it) 1987-10-02
NL8702234A (nl) 1988-05-02
SE8703788L (sv) 1988-04-04
FI874320A0 (fi) 1987-10-01
KR960002738B1 (ko) 1996-02-26
NO874143L (no) 1988-04-05
HUT47032A (en) 1989-01-30
CH678599A5 (sv) 1991-10-15
SE8703788D0 (sv) 1987-10-01

Similar Documents

Publication Publication Date Title
ES8802154A1 (es) Procedimiento para la produccion de tiazoles.,
ES2124479T3 (es) Composiciones biocidas.
NL194821B (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
MY101593A (en) Sustained release preparation.
ES8106509A1 (es) Procedimiento de preparar aril-3 ester-5 oxazolidinonas-2 y oxazolidinationas-2 nuevas
DE69116705T2 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
ES456944A1 (es) Un procedimiento para la preparacion de n-(5-tetrazolil)-4- oxo-4h-pirimido (2,1-b)benzotiazol-3-carboxamidas.
DK0411733T3 (da) 11-beta-aryl-gona-4,9-dien-3-oner
ES8507540A1 (es) Un procedimiento para preparar indeno-piridazinonas sustituidas.
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
ES8606339A1 (es) Procedimiento para la produccion de indolofenantridinas
ES8609728A1 (es) Una composicion de conjugado de enzima estabilizado
ES8105148A1 (es) Un procedimiento para la preparacion de una composicion far-maceutica de quinazolinonas analgesicas
BE1002058A4 (fr) Compositions pharmaceutiques a base d'urokinase.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
FR2593066B1 (fr) Compositions therapeutiques a base de derives de 3-alkoxyflavones et nouveaux derives de 3-alkoxyflavones.
ES8704469A1 (es) Procedimiento para preparar naftoxacinas
ES8205218A1 (es) Un procedimiento para la preparacion de pirrolilpiperidinas utiles como agentes antidepresivo.
DE3788028T2 (de) Photosensibilisatoren und polymerisierbare Zusammensetzungen.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
FR2626406B1 (fr) Transistor bipolaire compatible avec la technologie mos
BE903651A (fr) Alpha - (((2 - hydroxy -1,1- dimethyl - ethyl) amino) methyl), benzene methanol et ses sels, leurs procedes de preparation et leur utilisation.
ATE40132T1 (de) 1,4-dihydropyridin-derivate und diese enthaltende pharmazeutische praeparate.